bioRxivMicrobiologyPreprint
A 10-year longitudinal study reveals bat-driven SARSr-CoV evolution
Daphné de Riols de FonclareiD, Artur SzczepańskiiD, Aleksandra MilewskaiD, Sandrine Corbet, Lucile Rouilly, Laure DiancourtiD, Baptiste ElieiD, Sébastian LequimeiD, Bryce LeterrieriD, Sébastien J. PuechmailleiD, Frédéric TouzaliniD, Étienne DecrolyiD, Astrid VabretiD, Sophie Le PoderiD, Krzysztof PyrćiD, Meriadeg Ar GouilhiD
- Citations
- 0
Abstract
Bats are recognized reservoirs for several zoonoses and have an exceptional tolerance to viruses, likely linked with strong evolutionary selection in immune genes. Notably, in light of the emergence history of severe acute respiratory syndrome coronavirus (SARS-CoV), SARS-CoV-2 is hypothesized to have originated from Rhinolophus bats as well. In-depth studies are still needed, however, to unravel how SARS-related coronaviruses (SARSr-CoVs) persist and thrive in nature through evolution, virus-host interactions, and cross-species transmission. Here we present a pioneering 10-year longitudinal study of BBCoV-EPI1, a SARSr-CoV in Rhinolophus bats that revealed the complexity of virus-host interactions and the tempo at which new viral lineages emerge. Our results demonstrated the impacts of host life cycles (hibernation, female gathering, weaning juveniles, and mating periods) on strong seasonal oscillations in viral prevalence. These pronounced fluctuations drove viral diversification through bottlenecks, founder effects and Darwinian selection, counterbalanced by high mutation rates, fast gradualism, and recombination. We also found that host-cell enzymes are major contributors to BBCoV-EPI1 evolution in bats. The antiviral effect of APOBEC3 detected here in bats is weaker than it is in humans. Conversely, the ADAR enzyme had an unexpectedly strong and beneficial influence on viral evolution, even though the high mutation rate of RNA viruses is usually attributed to viral polymerases' low replication fidelity. We discovered that key BBCoV-EPI1 innovations in Rhinolophus bats were mostly located in proteins involved in cell-cycle hijack and in blocking bat cells' antiviral response, rather than in the Spike (S). We also showed that the BBCoV-EPI1 S protein efficiently uses angiotensin-converting enzyme 2 (ACE2) receptor to enter Rhinolophus bat cells, but not to enter human or sympatric species cells, due to amino-acid differences at the S-ACE2 interface. Last, this work identifies 101 critical amino-acid changes frequently associated with viral fitness shift, and paves the way for future experimental studies focusing on the capacity of SARSr-CoVs to adapt to hosts and cross the species barrier.
- organism: mouse
- organism: human
- organism: rat
- assay: metagenomics
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: ecology & biodiversity
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes
H. Guo, B. Hu, … Z. Shi·Journal of VirologyPeer-reviewed·Sep 29, 2020
- Origin and cross-species transmission of bat coronaviruses in China
A. Latinne, B. Hu, … P. Daszak·bioRxiv·May 31, 2020
- Natural selection in the evolution of SARS-CoV-2 in bats, not humans, created a highly capable human pathogen
O. A. MacLean, S. Lytras, … D. L. Robertson·bioRxiv·May 28, 2020
- Evolutionary Dynamics And Geographic Dispersal Of Beta Coronaviruses In African Bats
B. O. Motayo, O. O. Oluwasemowo, P. A. Akinduti·PeerJPeer-reviewed·Nov 26, 2020
- ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
T. N. Starr, S. K. Zepeda, … J. D. Bloom·bioRxiv·Jul 17, 2021
- Protein covariance networks reveal interactions important to the emergence of SARS coronaviruses as human pathogens
William Paul Robins, John J. Mekalanos·bioRxiv·Jun 5, 2020